A cyclometalated iridium(III) complex induces apoptosis and autophagy through inhibition of the PI3K/AKT/mTOR pathway

An iridium(III) complex [Ir(ppy)(2)(MHPIP)]PF6 (ppy = 2-phenylpyridine, MHPIP = 2-(1-methyl-1H-pyrazol-3-yl)-1H-imidazo[4,5-f][1, 10]phenanthroline, Ir-1) was synthesized and characterized by elemental analysis, IR, H-1 NMR and C-13 NMR. The in vitro cytotoxic activities of the free proligand MHPIP and the complex Ir-1 against HepG2, A549, BEL-7402, SGC-7901 and normal LO2 cells were evaluated by the MTT method. MHPIP has no cytotoxic activity toward the selected cell lines, while Ir-1 shows a moderate cytotoxic effect against HepG2. This complex also displays no cytotoxicity against normal LO2 cells, with an IC50 of more than 200 A mu M. The apoptosis of HepG2 cells induced by the complex was studied with AO/EB and DAPI staining methods, which showed that the complex can effectively induce apoptosis. A comet assay was performed by gel electrophoresis, and the results further show that the complex can cause apoptosis. The level of reactive oxygen species, mitochondrial membrane potential, autophagy, intracellular Ca2+ levels and cell invasion were investigated by fluorescence microscopy, and the cell cycle arrest was studied by flow cytometry. The expression of caspase and Bcl-2 family proteins was investigated by western blot. The results of these experiments indicate that Ir-1 accumulates preferentially in the mitochondria of HepG2 cells and induces apoptosis through inhibition of the PI3K/AKT/mTOR pathway.